Literature DB >> 23342183

Critical limb ischemia: reporting outcomes and quality.

Mark G Davies1.   

Abstract

The impetus to pursue quality in limb salvage is high in the current economic environment. This has been spurred on by the diffusion of multiple technologies, the lack of well-defined cost-effectiveness benchmarks, and the paucity of process and structure benchmarks. Furthermore, no national database exists to capture current activity and trends, and lead structure and process changes that could analyze outcomes and improve standards in peripheral interventions for limb salvage. This manuscript examines the challenges in measuring outcomes and quality in limb salvage and explores the components necessary for ensuring quality in limb salvage interventions.

Entities:  

Keywords:  benchmarks; clinical pathways; cost effectiveness; critical limb ischemia; endovascular interventions; limb salvage; objective performance goals; outcomes; patient safety; patient safety organization; peripheral interventions; quality improvement; quality reporting; risk stratification

Mesh:

Year:  2012        PMID: 23342183      PMCID: PMC3549645          DOI: 10.14797/mdcj-8-4-15

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN: 1947-6108


  22 in total

1.  Does a standardization tool to direct invasive therapy for symptomatic lower extremity peripheral arterial disease improve outcomes?

Authors:  Mark P Androes; Corey A Kalbaugh; Spence M Taylor; Dawn W Blackhurst; Guy E McClary; Bruce H Gray; Eugene M Langan; Rebecca A Caldwell; Tod M Hanover; John W York; Marcus D Stanbro; Jerry R Youkey
Journal:  J Vasc Surg       Date:  2004-11       Impact factor: 4.268

2.  Trends, complications, and mortality in peripheral vascular surgery.

Authors:  Roman Nowygrod; Natalia Egorova; Giampaolo Greco; Patrice Anderson; Annetine Gelijns; Alan Moskowitz; James McKinsey; Nicholas Morrissey; K Craig Kent
Journal:  J Vasc Surg       Date:  2006-02       Impact factor: 4.268

Review 3.  Clinical Pathways in surgery: should we introduce them into clinical routine? A review article.

Authors:  Ulrich Ronellenfitsch; Eric Rössner; Jens Jakob; Stefan Post; Peter Hohenberger; Matthias Schwarzbach
Journal:  Langenbecks Arch Surg       Date:  2008-02-23       Impact factor: 3.445

Review 4.  Integrated care pathways.

Authors:  H Campbell; R Hotchkiss; N Bradshaw; M Porteous
Journal:  BMJ       Date:  1998-01-10

5.  Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia.

Authors:  Andres Schanzer; Nathanael Hevelone; Christopher D Owens; Joshua A Beckman; Michael Belkin; Michael S Conte
Journal:  J Vasc Surg       Date:  2008-04       Impact factor: 4.268

6.  A simple subclassification of American Society of Anesthesiology III patients undergoing peripheral revascularization based on functional capacity.

Authors:  Hasan H Dosluoglu; Jiping Wang; Leslie Defranks-Anain; Miguel Rainstein; Nader D Nader
Journal:  J Vasc Surg       Date:  2008-02-14       Impact factor: 4.268

7.  A regional registry for quality assurance and improvement: the Vascular Study Group of Northern New England (VSGNNE).

Authors:  Jack L Cronenwett; Donald S Likosky; Margaret T Russell; Jens Eldrup-Jorgensen; Andrew C Stanley; Brian W Nolan
Journal:  J Vasc Surg       Date:  2007-10-24       Impact factor: 4.268

8.  [The importance of assessing the "quality of life" in surgical interventions for critical lower limb ischaemia].

Authors:  László Papp
Journal:  Magy Seb       Date:  2004-02

9.  Impact of clinical pathways on hospital costs and early outcome after major vascular surgery.

Authors:  K D Calligaro; M J Dougherty; C A Raviola; D J Musser; D A DeLaurentis
Journal:  J Vasc Surg       Date:  1995-12       Impact factor: 4.268

Review 10.  Impact of outcomes research on the management of vascular surgery patients.

Authors:  John E Rectenwald; Gilbert R Upchurch
Journal:  J Vasc Surg       Date:  2007-06       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.